Claudio C Prieto (Claudio Prieto)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Angiotensin Converting Enzyme

Protein Protein

Top Venues

Applied microbiology and biotechnology

The protein journal

Biotechnology journal

This page only lists publications with an associated author ORCID identifier.

Publications

Javier Villarraza, Sebastián Antuña, María Belén Tardivo, María Celeste Rodríguez, Pablo Uriel Díaz, Ulises Sebastián Notaro, Hugo Héctor Ortega, Claudio C Prieto, Natalia Ceaglio
Development of a biotechnology process for the production of a novel hyperglycosylated long-acting recombinant bovine follicle-stimulating hormone. Biotechnology journal 19 (6) (2024)
Javier Villarraza, Sebastián Antuña, María Belén Tardivo, María Celeste Rodríguez, Pablo Uriel Díaz, Ulises Sebastián Notaro, Hugo Héctor Ortega, Claudio C Prieto, Natalia Ceaglio
Development of a biotechnology process for the production of a novel hyperglycosylated long-acting recombinant bovine follicle-stimulating hormone. Biotechnology journal 19 (6) (2024)
Javier Villarraza, Sebastián Antuña, María Belén Tardivo, María Celeste Rodríguez, Pablo Uriel Díaz, Ulises Sebastián Notaro, Hugo Héctor Ortega, Claudio C Prieto, Natalia Ceaglio
Development of a biotechnology process for the production of a novel hyperglycosylated long-acting recombinant bovine follicle-stimulating hormone. Biotechnology journal 19 (6) (2024)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
María Celeste Rodríguez, Pablo Esteban Mussio, Javier Villarraza, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Natalia Ceaglio, Claudio C Prieto
Physicochemical Characterization of a Recombinant eCG and Comparative Studies with PMSG Commercial Preparations. The protein journal 42 (1) (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology 107 (11) (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology 107 (11) (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology 107 (11) (2023)
María Celeste Rodríguez, Pablo Esteban Mussio, Javier Villarraza, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Natalia Ceaglio, Claudio C Prieto
Physicochemical Characterization of a Recombinant eCG and Comparative Studies with PMSG Commercial Preparations. The protein journal 42 (1) (2023)
María Celeste Rodríguez, Pablo Esteban Mussio, Javier Villarraza, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Natalia Ceaglio, Claudio C Prieto
Physicochemical Characterization of a Recombinant eCG and Comparative Studies with PMSG Commercial Preparations. The protein journal (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
Javier Villarraza, Antonela Fuselli, Agustina Gugliotta, Ernesto Garay, María Celeste Rodríguez, Diego Fontana, Sebastián Antuña, Victoria Gastaldi, Juan Manuel Battagliotti, María Belén Tardivo, Diego E Álvarez, Eliana F Castro, Juliana Cassataro, Natalia Ceaglio, Claudio C Prieto
A COVID-19 vaccine candidate based on SARS-CoV-2 spike protein and immune-stimulating complexes. Applied microbiology and biotechnology (2023)
María Celeste Rodríguez, Pablo Esteban Mussio, Javier Villarraza, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Natalia Ceaglio, Claudio C Prieto
Physicochemical Characterization of a Recombinant eCG and Comparative Studies with PMSG Commercial Preparations. The protein journal 42 (1) (2023)
María Celeste Rodríguez, Pablo Esteban Mussio, Javier Villarraza, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Natalia Ceaglio, Claudio C Prieto
Physicochemical Characterization of a Recombinant eCG and Comparative Studies with PMSG Commercial Preparations. The protein journal 42 (1) (2023)
María Celeste Rodríguez, Natalia Ceaglio, Agustina Gugliotta, Javier Villarraza, Ernesto Garay, Antonela Fuselli, Victoria Gastaldi, María Belén Tardivo, Sebastián Antuña, Diego Fontana, Claudio C Prieto
Design and optimization of an IgG human ELISA assay reactive to recombinant RBD SARS-CoV-2 protein. Applied microbiology and biotechnology 106 (23) (2022)
Antonela Fuselli, María de Los Milagros Bürgi, Ricardo B Kratje, Claudio C Prieto
Generation and functional evaluation of novel monoclonal antibodies targeting glycosylated human stem cell factor. Applied microbiology and biotechnology 106 (24) (2022)
Ernesto Garay, Diego Fontana, Lautaro Leschiutta, Ricardo B Kratje, Claudio C Prieto
Rational design of novel fusion rabies glycoproteins displaying a major antigenic site of foot-and-mouth disease virus for vaccine applications. Applied microbiology and biotechnology 106 (2) (2021)
Diego Fontana, Ernesto Garay, Laura Cervera, Ricardo Kratje, Claudio C Prieto, Francesc Gòdia
Chimeric VLPs Based on HIV-1 Gag and a Fusion Rabies Glycoprotein Induce Specific Antibodies against Rabies and Foot-and-Mouth Disease Virus. Vaccines 9 (3) (2021)
María Celeste Rodríguez, Diego Fontana, Ernesto Garay, Claudio C Prieto
Detection and quantification of anti-rabies glycoprotein antibodies: current state and perspectives. Applied microbiology and biotechnology 105 (18) (2021)
Eduardo F Mufarrege, Evangelina L Benizio, Claudio C Prieto, Fabricio A Chiappini, María Celeste Rodríguez, Marina Etcheverrigaray, Ricardo B Kratje
Development of Magoh protein-overexpressing HEK cells for optimized therapeutic protein production. Biotechnology and applied biochemistry 68 (2) (2020)